460 related articles for article (PubMed ID: 16503051)
1. [Influenza virus of seasonal influenza , high increase of resistance to amantadine and rimantadine].
Nau JY
Rev Med Suisse; 2006 Jan; 2(50):308. PubMed ID: 16503051
[No Abstract] [Full Text] [Related]
2. Antiviral resistance in influenza viruses--implications for management and pandemic response.
Hayden FG
N Engl J Med; 2006 Feb; 354(8):785-8. PubMed ID: 16495389
[No Abstract] [Full Text] [Related]
3. Amantadine-resistant influenza A (H3N2) virus in Japan, 2005-2006.
Saito R; Li D; Suzuki H
N Engl J Med; 2007 Jan; 356(3):312-3. PubMed ID: 17229966
[No Abstract] [Full Text] [Related]
4. Emergence and phylogenetic relationships of amantadine-resistant human H3N2 influenza A viruses in Germany in the season 2005/2006.
Schmidtke M; Bauer K; Ludwig N; Wutzler P
Int J Antimicrob Agents; 2008 Aug; 32(2):192-5. PubMed ID: 18571381
[No Abstract] [Full Text] [Related]
5. Amantadine resistance in relation to the evolution of influenza A(H3N2) viruses in Iran.
Yavarian J; Azad TM; Zheng X; Gregory V; Lin YP; Hay A
Antiviral Res; 2010 Nov; 88(2):193-6. PubMed ID: 20816700
[TBL] [Abstract][Full Text] [Related]
6. Antivirals and influenza: frequency of resistance.
Monto AS
Pediatr Infect Dis J; 2008 Oct; 27(10 Suppl):S110-2. PubMed ID: 18820569
[TBL] [Abstract][Full Text] [Related]
7. Antiviral management of seasonal and pandemic influenza.
Hayden FG; Pavia AT
J Infect Dis; 2006 Nov; 194 Suppl 2():S119-26. PubMed ID: 17163384
[TBL] [Abstract][Full Text] [Related]
8. Influenza antiviral prescribing practices during the 2007-08 and 2008-09 influenza seasons in the setting of increased resistance to oseltamivir among circulating influenza viruses.
Dharan NJ; Beekmann SE; Fiore A; Finelli L; Uyeki TM; Polgreen PM; Fry AM
Antiviral Res; 2010 Nov; 88(2):182-6. PubMed ID: 20739002
[TBL] [Abstract][Full Text] [Related]
9. [Resistance to amantadine of epidemic strain of H3 subtype influenza virus: a primary study].
Xu H; Qian Y; Xu H; Zhang JH; Zhu RN; Wang F
Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(14):996-8. PubMed ID: 16759544
[TBL] [Abstract][Full Text] [Related]
10. HHS-CDC NEWS: update: influenza activity--US and worldwide, 2005-2006 season, and composition of the 2006-2007 influenza vaccine.
Ann Pharmacother; 2006; 40(7-8):1499-500. PubMed ID: 16849615
[No Abstract] [Full Text] [Related]
11. Surveillance of resistance to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated worldwide.
Deyde VM; Xu X; Bright RA; Shaw M; Smith CB; Zhang Y; Shu Y; Gubareva LV; Cox NJ; Klimov AI
J Infect Dis; 2007 Jul; 196(2):249-57. PubMed ID: 17570112
[TBL] [Abstract][Full Text] [Related]
12. Amantadine may be lifesaving in severe influenza A.
Cunha BA
Clin Infect Dis; 2006 Nov; 43(10):1372-3. PubMed ID: 17051511
[No Abstract] [Full Text] [Related]
13. Increased incidence of adamantane-resistant influenza A(H1N1) and A(H3N2) viruses during the 2006-2007 influenza season in Japan.
Saito R; Suzuki Y; Li D; Zaraket H; Sato I; Masaki H; Kawashima T; Hibi S; Sano Y; Shobugawa Y; Oguma T; Suzuki H
J Infect Dis; 2008 Feb; 197(4):630-2; author reply 632-3. PubMed ID: 18275281
[No Abstract] [Full Text] [Related]
14. High prevalence of amantadine-resistant influenza A virus isolated in Gyeonggi Province, South Korea, during 2005-2010.
Cho HG; Choi JH; Kim WH; Hong HK; Yoon MH; Jho EH; Kang C; Lim YH
Arch Virol; 2013 Jan; 158(1):241-5. PubMed ID: 23011311
[TBL] [Abstract][Full Text] [Related]
15. [New adamantane derivatives and ways of overcoming the resistance of influenza A viruses to rimantadine and amantadine].
Shibnev VA; Garayev TM; Finogenova MP; Shevchenko ES; Burtseva EI
Vopr Virusol; 2011; 56(2):36-9. PubMed ID: 21545040
[TBL] [Abstract][Full Text] [Related]
16. High frequency of amantadine-resistant influenza A (H3N2) viruses in the 2005-2006 season and rapid detection of amantadine-resistant influenza A (H3N2) viruses by MAMA-PCR.
Hata M; Tsuzuki M; Goto Y; Kumagai N; Harada M; Hashimoto M; Tanaka S; Sakae K; Kimura T; Minagawa H; Miyazaki Y
Jpn J Infect Dis; 2007 Jul; 60(4):202-4. PubMed ID: 17642534
[TBL] [Abstract][Full Text] [Related]
17. High prevalence of amantadine-resistance influenza a (H3N2) in six prefectures, Japan, in the 2005-2006 season.
Saito R; Li D; Suzuki Y; Sato I; Masaki H; Nishimura H; Kawashima T; Shirahige Y; Shimomura C; Asoh N; Degawa S; Ishikawa H; Sato M; Shobugawa Y; Suzuki H
J Med Virol; 2007 Oct; 79(10):1569-76. PubMed ID: 17705168
[TBL] [Abstract][Full Text] [Related]
18. Amantadine-resistant influenza A viruses isolated in South Korea from 2003 to 2009.
Choi WY; Kim S; Lee N; Kwon M; Yang I; Kim MJ; Cheong SG; Kwon D; Lee JY; Oh HB; Kang C
Antiviral Res; 2009 Nov; 84(2):199-202. PubMed ID: 19720085
[TBL] [Abstract][Full Text] [Related]
19. [Prophylaxis and treatment of respiratory infections caused by influenza virus types A and B].
Reina J
Rev Esp Quimioter; 1999 Mar; 12(1):23-9. PubMed ID: 10209061
[No Abstract] [Full Text] [Related]
20. Isolation of amantadine-resistant influenza a viruses (H3N2) from patients following administration of amantadine in Japan.
Iwahashi J; Tsuji K; Ishibashi T; Kajiwara J; Imamura Y; Mori R; Hara K; Kashiwagi T; Ohtsu Y; Hamada N; Maeda H; Toyoda M; Toyoda T
J Clin Microbiol; 2001 Apr; 39(4):1652-3. PubMed ID: 11283109
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
